ArticleScientific reports2025
Travel burden increases the risk of advanced stage at diagnosis of breast cancer in Kashgar, China.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Public health determinants of screening accessibility, diagnostic and treatment timeliness, care adherence, and survival outcomes in breast cancer patients.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Early breast cancer detection rates are low in Kashgar, Xinjiang, China, potentially due to poor spatial accessibility to diagnostic services. This study examined the association between travel burden from patient residences to hospitals and the stage of breast cancer at diagnosis in this population. We analyzed data from 981 female patients (aged > 20 years) diagnosed with breast cancer at the First People's Hospital of Kashgar between 2019 and 2022. Driving distances were calculated using the Baidu Maps API. Multivariable multinomial and binary logistic regression models were used. 29.9% of the sample were diagnosed at an advanced stage of disease. Residing more than 20 km from secondary hospitals increased the relative risk of advanced-stage diagnosis by 1.61-fold (95% CI: 1.20-2.31, vs. early-stage) and the odds by 1.48 times (95% CI: 1.07-2.05, vs. non-advanced stage). Similarly, living more than 80 km from tertiary hospitals was associated with an elevated relative risk (RRR = 1.38; 95% CI: 1.08-1.75, vs. early-stage) and 1.40 times the odds (95% CI: 1.04-1.90, vs. non-advanced stage) of advanced-stage diagnosis. Longer travel distances to both secondary and tertiary hospitals are associated with increased risks of advanced-stage breast cancer at diagnosis in Kashgar. Enhancing spatial accessibility to diagnostic services is crucial for improving early detection and potentially downstaging breast cancer in this and similar remote regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.